Cargando…

Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing

PTEN-associated clinical syndromes such as Cowden syndrome (CS) increase cancer risk and have historically been diagnosed based upon phenotypic criteria. Because not all patients clinically diagnosed with CS have PTEN pathogenic variants (PVs), and not all patients with PTEN PVs have been clinically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cummings, Shelly, Alfonso, Andrew, Hughes, Elisha, Kucera, Matt, Mabey, Brent, Singh, Nanda, Eng, Charis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928870/ https://www.ncbi.nlm.nih.gov/pubmed/36634299 http://dx.doi.org/10.1200/PO.22.00415

Ejemplares similares

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
por: Ryu, Jin‐Sun, et al.
Publicado: (2020)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
por: Hu, Chunling, et al.
Publicado: (2018)

Increased Co-Occurrence of Pathogenic Variants in Hereditary Breast and Ovarian Cancer and Lynch Syndromes: A Consequence of Multigene Panel Genetic Testing?
por: Infante, Mar, et al.
Publicado: (2022)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition
por: Martin-Morales, Lorena, et al.
Publicado: (2018)

Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
por: Calvello, Mariarosaria, et al.
Publicado: (2023)

TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing
por: Lesueur, Fabienne, et al.
Publicado: (2021)

Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
por: Nguyen-Dumont, Tú, et al.
Publicado: (2021)

Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
por: Liu, Yinfeng, et al.
Publicado: (2023)

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients
por: LaDuca, Holly, et al.
Publicado: (2014)

Genetic Variation and the Role of Multigene Panel Testing for Hereditary Breast Cancer: A Single-Institution Experience
por: Lu, Kit, et al.
Publicado: (2021)

Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families
por: Coppa, Anna, et al.
Publicado: (2017)

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
por: Eliade, Marie, et al.
Publicado: (2016)

Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes
por: Gardiner, Anna, et al.
Publicado: (2022)

Uptake and acceptability of a mainstreaming model of hereditary cancer multigene panel testing among patients with ovarian, pancreatic, and prostate cancer
por: Hamilton, Jada G., et al.
Publicado: (2021)

Multigene panel predicting survival of patients with colon cancer
por: Li, Hao-Dong, et al.
Publicado: (2019)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer
por: Elsayegh, Nisreen, et al.
Publicado: (2018)

Detection of BRCA1 Pathogenic Variant in a 24-Year-Old Endometrial Cancer Patient: Risks of Several Hereditary Tumor Syndromes Assessed Using Germline Multigene Panel Testing
por: Wang, Xiaofei, et al.
Publicado: (2022)

Integration of multigene panels for the diagnosis of hereditary retinal disorders using Next Generation Sequencing and bioinformatics approaches
por: Di Resta, Chiara, et al.
Publicado: (2018)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer
por: Clark, Dana Farengo, et al.
Publicado: (2020)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel
por: AlHarbi, Musa, et al.
Publicado: (2023)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

The association between age at breast cancer diagnosis and prevalence of pathogenic variants
por: Daly, Mary B., et al.
Publicado: (2023)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
por: Li, Hongyan, et al.
Publicado: (2019)

Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition
por: Tedaldi, Gianluca, et al.
Publicado: (2019)

Multigene panel next generation sequencing in metastatic colorectal cancer in an Australian population
por: Nindra, Udit, et al.
Publicado: (2023)

Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer
por: Coughlin, Sarah E., et al.
Publicado: (2022)

Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation
por: Yu, Wanfeng, et al.
Publicado: (2015)

Germline multigene panel testing revealed a BRCA2 pathogenic variant in a patient with suspected Lynch syndrome
por: Yoshihama, Tomoko, et al.
Publicado: (2020)

Germline TTN variants are enriched in PTEN-wildtype Bannayan–Riley–Ruvalcaba syndrome
por: Yehia, Lamis, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2iuma8639daijsqsphqrajegnh